The market may have skipped the drama, but there’s no shortage of action in today’s headlines. From tariff truces to profit tumbles, pharma fireworks and a pair of energy stocks with more juice than a summer picnic. Here’s what you need to know as the closing bell rings.
1. Deal done, but no drama. The FTSE 100 barely budged after the US-EU tariff truce—markets had already priced in the peace, so there was no rally left to squeeze. Read more
2. GSK shares ticked higher as the pharma giant inked a $500 million deal with China’s Hengrui. Twelve experimental medicines and $12 billion in potential milestones. Breathless stuff, eh? Read more
3. Shares in STV took a nosedive, plunging 24% after the broadcaster cut forecasts. Weak ad sales and a tough commissioning climate put a gloomy filter on full-year profits. Read more
4. EnergyPathways jumped 17% after the government spotlighted energy storage. No guarantees yet, but Whitehall’s nod to new tech gives EP’s ambitious storage plans a shot of credibility. Read more
5. Ceres Power soared 44% as South Korea’s Doosan Fuel Cell fired up mass production. It’s the first commercial rollout for Ceres’ clean energy tech...and investors are loving it. Read more
And Proactive's pick of the small-caps
Kromek Group PLC (AIM:KMK) bags further $5 million from Siemens tie-up
Ariana Resources PLC (AIM:AAU) updates on ASX listing and fundraiser
Adriatic Metals PLC (LSE:ADT1, ASX:ADT, OTCQX:ADMLF) reports on production